Addison Capital CO Abbott Laboratories Transaction History

Addison Capital CO

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 07, 2024	BUY	$109.52 - $120.96 $10,952 - $12,096	100 Added 5.41%	1,950 $221,000
Q4 2023 Feb 08, 2024	BUY	$90.19 - $110.4 $166,851 - $204,240	1,850 New	1,850 $203,000
Q2 2023 Aug 18, 2023	BUY	$100.78 - $112.29 $186,443 - $207,736	1,850 New	1,850 $201,000
Q4 2022 Jan 09, 2023	BUY	$95.06 - $111.52 $175,861 - $206,312	1,850 New	1,850 $203,000
Q2 2021 Jul 16, 2021	BUY	$105.79 - $124.53 $195,711 - $230,380	1,850 New	1,850 $214,000

3,186

1.3B

8.74M

8.08M

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $206B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

Get notified when there are updates to the investment portfolio of Addison Capital CO, based on Form 13F filings with the SEC.

Stay updated on Addison Capital CO with notifications on news.